Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Macular Degeneration × Ranibizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 6 Retinal Diseases 2 Melanoma 2 Retinoblastoma 1 Neurofibromatosis 1 1 Neurofibroma 1 Macular Edema 1 Macular Degeneration 1 Glaucoma, Neovascular 1 Conjunctival Neoplasms 1 Choroid Diseases 1

Interventions

salicylhydroxamic acid 1 brolucizumab 1 aflibercept 1 Triamcinolone Acetonide 1 Ranibizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00811200 2009-07-02

TORR

Leiden University Medical Center

Phase 2/3 Unknown

Uveal Melanoma, Macular Degeneration, Melanoma, Retinal Diseases, Choroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡